𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand

✍ Scribed by Chatchalit Rattarasarn; Manuel Aguilar Diosdado; Supamai Soonthornpun

Book ID
117371393
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
65 KB
Volume
37
Category
Article
ISSN
0168-8227

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antibodies to Glutamic Acid Decarboxylas
Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Failure of Oral Hypoglycaemic Therapy
✍ Fukui, M.; Nakano, K.; Shigeta, H.; Yoshimori, K.; Fujii, M.; Kitagawa, Y.; Mori πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

Some patients with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) are positive for antibodies to glutamic acid decarboxylase (anti-GAD), which have been shown to be a useful marker for the diagnosis and prediction of insulin-dependent (Type 1) diabetes mellitus (IDDM). Anti-GAD positive NI

Elimination of islet cell antibodies and
Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus
✍ W. O. Richter; M. G. Donner; P. Schwandt πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune